Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

March 01, 2003; Volume 30,Issue 3
  • You have access
    Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?
    Sara M Carty, Neil Snowden and Alan J Silman
    The Journal of Rheumatology March 1 2003, 30 (3) 425-429;
  • You have access
    Bisphosphonates for arthritis--a confusing rationale.
    Walter P Maksymowych
    The Journal of Rheumatology March 1 2003, 30 (3) 430-434;
  • You have access
    Lack of association between -384 and 114 IL-2 gene polymorphisms and rheumatoid arthritis.
    Maria Fedetz, Fuencisla Matesanz, Rafael Cáliz, Miguel Angel Ferrer, Maria Dolores Collado, Antonio Alcina and Javier Martín
    The Journal of Rheumatology March 1 2003, 30 (3) 435-437;
  • You have access
    Tumor necrosis factor receptor 2 microsatellite and exon 6 polymorphisms in rheumatoid arthritis in Taiwan.
    Jeng-Hsien Yen, Wen-Chan Tsai, Chung-Jen Chen, Tsan-Teng Ou, Chia-Hui Lin, Chaur-Jong Hu and Hong-Wen Liu
    The Journal of Rheumatology March 1 2003, 30 (3) 438-442;
  • You have access
    Risk communication in rheumatoid arthritis.
    Liana Fraenkel, Sidney Bogardus, John Concato and David Felson
    The Journal of Rheumatology March 1 2003, 30 (3) 443-448;
  • You have access
    Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
    Arthur Kavanaugh, Mark Genovese, Jan Baughman, Alan Kivitz, Ken Bulpitt, Nancy Olsen, Michael Weisman, Eric Matteson, Daniel Furst, Ronald van Vollenhoven, James Anderson, Stanley Cohen, Nathan Wei, Jan Meijerink, Cindy Jacobs and Simonetta Mocci
    The Journal of Rheumatology March 1 2003, 30 (3) 449-454;
  • You have access
    Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study.
    Florence C Hsu, Gordon Starkebaum, Edward J Boyko and Jason A Dominitz
    The Journal of Rheumatology March 1 2003, 30 (3) 455-458;
  • You have access
    Infections preceding early arthritis in southern Sweden: a prospective population-based study.
    Maria K Söderlin, Hannu Kautiainen, Mirja Puolakkainen, Klaus Hedman, Maria Söderlund-Venermo, Thomas Skogh and Marjatta Leirisalo-Repo
    The Journal of Rheumatology March 1 2003, 30 (3) 459-464;
  • You have access
    A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis.
    Jolanda Cibere, Zhaozhi Deng, Yuanchang Lin, Runmei Ou, Yiting He, Zhiqiang Wang, Anona Thorne, Allen J Lehman, Ian K Tsang and John M Esdaile
    The Journal of Rheumatology March 1 2003, 30 (3) 465-467;
  • You have access
    Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease.
    Heikki Valleala, Leena Laasonen, Marja-Kaisa Koivula, Jami Mandelin, Claes Friman, Juha Risteli and Yrjö T Konttinen
    The Journal of Rheumatology March 1 2003, 30 (3) 468-473;
  • You have access
    Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis.
    Jun Hasegawa, Masakazu Nagashima, Munehiro Yamamoto, Tohru Nishijima, Shinichi Katsumata and Shinichi Yoshino
    The Journal of Rheumatology March 1 2003, 30 (3) 474-479;
  • You have access
    Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
    Janet Pope, Dana Jerome, Deborah Fenlon, Adriana Krizova and Janine Ouimet
    The Journal of Rheumatology March 1 2003, 30 (3) 480-484;
  • You have access
    Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
    Renata Dellalibera-Joviliano, Marina Lemos Dos Reis, Fernando de Queiroz Cunha and Eduardo Antonio Donadi
    The Journal of Rheumatology March 1 2003, 30 (3) 485-492;
  • You have access
    Cardiovascular risk factor screening in systemic lupus erythematosus.
    Adeeba Al-Herz, Stephanie Ensworth, Kamran Shojania and John M Esdaile
    The Journal of Rheumatology March 1 2003, 30 (3) 493-496;
  • You have access
    Cyclophosphamide adjuvant arthritis in Trypanosoma cruzi infected rats with inflammatory cytokine effects.
    Griselda Didoli, Maria Luisa Bay, Flavia Rondelli, Adriana del Rey, Hugo Besedovsky and Oscar Bottasso
    The Journal of Rheumatology March 1 2003, 30 (3) 497-504;
  • You have access
    HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis.
    Rubén Queiro, Juan Carlos Torre, Segundo González, Carlos López-Larrea, Tomás Tinturé and Isaac López-Lagunas
    The Journal of Rheumatology March 1 2003, 30 (3) 505-507;
  • You have access
    The structure and histopathology of the "enthesis organ" at the navicular insertion of the tendon of tibialis posterior.
    Bernhard Moriggl, Tsukasa Kumai, Stefan Milz and Michael Benjamin
    The Journal of Rheumatology March 1 2003, 30 (3) 508-517;
  • You have access
    Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease.
    Sophia Steer, Hugh Jones, Jane Hibbert, Elli Kondeatis, Robert Vaughan, Jeremy Sanderson and Terence Gibson
    The Journal of Rheumatology March 1 2003, 30 (3) 518-522;
  • You have access
    A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee.
    Marc Cohen, Rory Wolfe, Trudy Mai and Daniel Lewis
    The Journal of Rheumatology March 1 2003, 30 (3) 523-528;
  • You have access
    Men's shoes and knee joint torques relevant to the development and progression of knee osteoarthritis.
    D Casey Kerrigan, Mark E Karvosky, Jennifer L Lelas and Patrick O Riley
    The Journal of Rheumatology March 1 2003, 30 (3) 529-533;
  • You have access
    Joint-specific multidimensional assessment of pain (J-MAP): factor structure, reliability, validity, and responsiveness in patients with knee osteoarthritis.
    Kimberly J O'Malley, Maria Suarez-Almazor, Julie Aniol, Peter Richardson, David H Kuykendall, J Bruce Moseley Jr and Nelda P Wray
    The Journal of Rheumatology March 1 2003, 30 (3) 534-543;
  • You have access
    Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor.
    Richard L Leff, Ileana Elias, Mirela Ionescu, Agnes Reiner and A Robin Poole
    The Journal of Rheumatology March 1 2003, 30 (3) 544-549;
  • You have access
    Facilitation of fas mediated apoptosis of human chondrocytes by the proteasome inhibitor and actinomycin D.
    Hyun A Kim, Yong H Kim and Yeong W Song
    The Journal of Rheumatology March 1 2003, 30 (3) 550-558;
  • You have access
    Apoptosis and p53 expression in chondrocytes relate to degeneration in articular cartilage of immobilized knee joints.
    Ryuji Okazaki, Akinori Sakai, Akira Ootsuyama, Takeshi Sakata, Toshitaka Nakamura and Toshiyuki Norimura
    The Journal of Rheumatology March 1 2003, 30 (3) 559-566;
  • You have access
    What do tender points measure? Influence of distress on 4 measures of tenderness.
    Frank Petzke, Richard H Gracely, Karen M Park, Kirsten Ambrose and Daniel J Clauw
    The Journal of Rheumatology March 1 2003, 30 (3) 567-574;
  • You have access
    Workshop report: knowledge translation of musculoskeletal health research.
    Peter S L Tugwell, Ann Qualman and Maria G Judd
    The Journal of Rheumatology March 1 2003, 30 (3) 575-578;
  • You have access
    Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup.
    Flavio Fantini, Valeria Gerloni, Maurizio Gattinara, Rolando Cimaz, Cristina Arnoldi and Elide Lupi
    The Journal of Rheumatology March 1 2003, 30 (3) 579-584;
  • You have access
    Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations.
    Kiem Oen, Peter N Malleson, David A Cabral, Alan M Rosenberg, Ross E Petty, Martin Reed, Marlis L Schroeder and Mary Cheang
    The Journal of Rheumatology March 1 2003, 30 (3) 585-593;
  • You have access
    Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial.
    Yosef Uziel, Matitiahu Berkovitch, Madlen Gazarian, Gideon Koren, Earl D Silverman, Rayfel Schneider and Ronald M Laxer
    The Journal of Rheumatology March 1 2003, 30 (3) 594-596;
  • You have access
    The publication rate of abstracts from the 4th Park City Pediatric Rheumatology meeting in peer-reviewed journals: what factors influenced publication?
    Philip Hashkes, Yosef Uziel and 4th Park City Pediatric Rheumatology
    The Journal of Rheumatology March 1 2003, 30 (3) 597-602;
  • You have access
    Defining Clinical Improvement in Adult and Juvenile Myositis.
    Lisa G Rider, Edward H Giannini, Michael Harris-Love, Galen Joe, David Isenberg, Clarissa Pilkington, Peter A Lachenbruch, Frederick W Miller and International Myositis Assesment and Clinical Studies Group
    The Journal of Rheumatology March 1 2003, 30 (3) 603-617;
  • You have access
    Familial vasculitides: Churg-Strauss syndrome and Wegener's granulomatosis in 2 first-degree relatives.
    Paolo Manganelli, Roberto Giacosa, Pieranna Fietta, Adele Zanetti and Tauro Maria Neri
    The Journal of Rheumatology March 1 2003, 30 (3) 618-621;
  • You have access
    Kaposi's sarcoma following immune suppressive therapy for Wegener's granulomatosis.
    Isabelle Deschênes, Louise Dion, Claude Beauchesne and Artur de Brum-Fernandes
    The Journal of Rheumatology March 1 2003, 30 (3) 622-624;
  • You have access
    Bilateral optic nerve sheath enhancement from giant cell arteritis.
    Kenneth E Morgenstern, Brian D Ellis, Sidney S Schochet and John V Linberg
    The Journal of Rheumatology March 1 2003, 30 (3) 625-627;
  • You have access
    Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
    Leon Margolin
    The Journal of Rheumatology March 1 2003, 30 (3) 628-629;
  • You have access
    Ankylosing tarsitis.
    Mythili Seetharaman and Lawrence H Brent
    The Journal of Rheumatology March 1 2003, 30 (3) 630-631;
  • You have access
    Septic discitis as a complication of infective endocarditis caused by Streptococcus oralis.
    Udaya P Udayaraj, Nagui S T Gendi and Elsir M Osman
    The Journal of Rheumatology March 1 2003, 30 (3) 632-633;
  • You have access
    An unusual cause of loin pain in a patient with systemic lupus erythematosus.
    Kam Hon Yoon and Poh Sun Goh
    The Journal of Rheumatology March 1 2003, 30 (3) 634-635;
  • You have access
    Why "spondylodiscitis," why "SAPHO syndrome"?
    Fritz Schilling
    The Journal of Rheumatology March 1 2003, 30 (3) 636;
  • You have access
    Mycobacterium tuberculosis infection of a tophaceous pseudogout nodule.
    H Ralph Schumacher Jr
    The Journal of Rheumatology March 1 2003, 30 (3) 637;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 30, Issue 3
1 Mar 2003
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Ro52, Myositis, and Interstitial Lung Disease
  • Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
  • Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire